Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of August 2026

  1. Perrigo Company

    World Rank (Aug-2026)
    6,711
    Market Cap (Aug-2026)
    1.810 Billion USD
    World Rank (Jan-05-2024)
    3,172
    Market Cap (Jan-05-2024)
    4.552 Billion USD
    World Rank (Jul-30-2023)
    3,003
    Market Cap (Jul-30-2023)
    4.946 Billion USD
    World Rank (Dec-25-2022)
    3,011
    Market Cap (Dec-25-2022)
    4.446 Billion USD
    World Rank (Jan-07-2022)
    3,057
    Market Cap (Jan-07-2022)
    5.45 Billion USD
    Annual Revenue in USD
    4,451 Million USD
    Annual Operating Income in USD
    121 Million USD
    Annual Net Income in USD
    -140 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Perrigo is a leading global healthcare company, focused on providing value to its customers and consumers by delivering Quality Affordable Healthcare Products. Perrigo has built a unique business model that is best described as the convergence of a fast-moving consumer goods company, a high-quality pharmaceutical manufacturing organization and a world-class supply chain network. Perrigo is the world's largest manufacturer of OTC healthcare products and supplier of infant formulas for the store brand market.
  2. Zymeworks

    World Rank (Aug-2026)
    6,788
    Market Cap (Aug-2026)
    1.782 Billion USD
    World Rank (Jan-05-2024)
    10,077
    Market Cap (Jan-05-2024)
    0.758 Billion USD
    World Rank (Jul-30-2023)
    13,171
    Market Cap (Jul-30-2023)
    0.467 Billion USD
    World Rank (Dec-25-2022)
    12,463
    Market Cap (Dec-25-2022)
    0.496 Billion USD
    World Rank (Jan-07-2022)
    11,722
    Market Cap (Jan-07-2022)
    0.66 Billion USD
    Annual Revenue in USD
    20 Million USD
    Annual Net Income in USD
    -162 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Zymeworks is a clinical Stage Biotechnology company. The company dedicated to the discovery, development, and commercialization of next generation multifunctional biotherapeutics initially focused on the treatment of cancer. The headquarters is in Canada.
  3. Syndax Pharmaceuticals

    World Rank (Aug-2026)
    6,806
    Market Cap (Aug-2026)
    1.772 Billion USD
    World Rank (Jan-05-2024)
    6,088
    Market Cap (Jan-05-2024)
    1.788 Billion USD
    World Rank (Jul-30-2023)
    6,989
    Market Cap (Jul-30-2023)
    1.461 Billion USD
    World Rank (Dec-25-2022)
    6,132
    Market Cap (Dec-25-2022)
    1.655 Billion USD
    World Rank (Jan-07-2022)
    9,280
    Market Cap (Jan-07-2022)
    1.03 Billion USD
    Annual Revenue in USD
    172 Million USD
    Annual Operating Income in USD
    -273 Million USD
    Annual Net Income in USD
    -285 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Syndax Pharmaceuticals is a Clinical Stage Biopharmaceutical company developing an innovative pipeline of cancer therapies. The company annual revenue is 1.5 million USD and 38 employees as on 2019. The headquarters is in USA.
  4. ANI Pharmaceuticals Inc.

    World Rank (Aug-2026)
    6,839
    Market Cap (Aug-2026)
    1.757 Billion USD
    World Rank (Jan-05-2024)
    7,914
    Market Cap (Jan-05-2024)
    1.149 Billion USD
    World Rank (Jul-30-2023)
    8,477
    Market Cap (Jul-30-2023)
    1.055 Billion USD
    World Rank (Dec-25-2022)
    10,448
    Market Cap (Dec-25-2022)
    0.689 Billion USD
    World Rank (Jan-07-2022)
    11,253
    Market Cap (Jan-07-2022)
    0.73 Billion USD
    Annual Revenue in USD
    883 Million USD
    Annual Operating Income in USD
    111 Million USD
    Annual Net Income in USD
    78 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    ANI Pharmaceuticals is an Integrated Specialty Pharmaceutical company. It is focused on delivering value to customers by developing, manufacturing and marketing high quality branded and generic prescription pharmaceuticals. The company annual revenue is 206.5 million USD and 338 employees as on 2019. The headquarters is in USA.
  5. Xencor

    World Rank (Aug-2026)
    6,884
    Market Cap (Aug-2026)
    1.735 Billion USD
    World Rank (Jan-05-2024)
    7,236
    Market Cap (Jan-05-2024)
    1.346 Billion USD
    World Rank (Jul-30-2023)
    7,028
    Market Cap (Jul-30-2023)
    1.449 Billion USD
    World Rank (Dec-25-2022)
    6,390
    Market Cap (Dec-25-2022)
    1.564 Billion USD
    World Rank (Jan-07-2022)
    5,875
    Market Cap (Jan-07-2022)
    2.22 Billion USD
    Annual Revenue in USD
    126 Million USD
    Annual Operating Income in USD
    -178 Million USD
    Annual Net Income in USD
    -92 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Xencor is a Clinical Stage Biopharmaceutical company. It has portfolio of 18 proprietary and partnered therapeutic antibody and cytokine programs in clinical development for the treatment of cancer autoimmune disorders and infectious disease. The headquarters is in USA.
    Facts About Company
    As on 2021, Xencor had 254 full-time employees.
  6. AnaptysBio Inc.

    World Rank (Aug-2026)
    6,897
    Market Cap (Aug-2026)
    1.731 Billion USD
    World Rank (Jan-05-2024)
    11,751
    Market Cap (Jan-05-2024)
    0.575 Billion USD
    World Rank (Jul-30-2023)
    13,367
    Market Cap (Jul-30-2023)
    0.453 Billion USD
    World Rank (Dec-25-2022)
    9,383
    Market Cap (Dec-25-2022)
    0.831 Billion USD
    World Rank (Jan-07-2022)
    9,972
    Market Cap (Jan-07-2022)
    0.91 Billion USD
    Annual Revenue in USD
    235 Million USD
    Annual Operating Income in USD
    48 Million USD
    Annual Net Income in USD
    -13 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    AnaptysBio is a Clinical Stage Biotechnology company developing first in class immunology therapeutic product candidates to patients. The company annual revenue is 75 million USD and 89 employees as on 2020. The headquarters is in USA.
  7. BioLife Solutions Inc.

    World Rank (Aug-2026)
    6,929
    Market Cap (Aug-2026)
    1.715 Billion USD
    World Rank (Jan-05-2024)
    10,505
    Market Cap (Jan-05-2024)
    0.707 Billion USD
    World Rank (Jul-30-2023)
    9,534
    Market Cap (Jul-30-2023)
    0.858 Billion USD
    World Rank (Dec-25-2022)
    9,928
    Market Cap (Dec-25-2022)
    0.755 Billion USD
    World Rank (Jan-07-2022)
    8,152
    Market Cap (Jan-07-2022)
    1.28 Billion USD
    Annual Revenue in USD
    96 Million USD
    Annual Operating Income in USD
    -17 Million USD
    Annual Net Income in USD
    -5 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    BioLife Solutions is a supplier of class defining cell and Gene Therapy Bioproduction tools and services company. The headquarters is in USA.
    Facts About Company
    BioLife Solutions company annual revenue was 161 million USD and annual net loss was -139 as on 2019.
  8. Recursion Pharmaceuticals Inc.

    World Rank (Aug-2026)
    6,978
    Market Cap (Aug-2026)
    1.692 Billion USD
    World Rank (Jan-05-2024)
    5,212
    Market Cap (Jan-05-2024)
    2.314 Billion USD
    World Rank (Jul-30-2023)
    4,907
    Market Cap (Jul-30-2023)
    2.524 Billion USD
    World Rank (Dec-25-2022)
    6,761
    Market Cap (Dec-25-2022)
    1.424 Billion USD
    World Rank (Jan-07-2022)
    5,259
    Market Cap (Jan-07-2022)
    2.67 Billion USD
    Annual Revenue in USD
    75 Million USD
    Annual Operating Income in USD
    -648 Million USD
    Annual Net Income in USD
    -645 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Recursion Pharmaceuticals, Inc. is a clinical stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering to industrialize drug discovery. The company annual revenue is 10 million USD and net loss of 186 Million USD as on 2021. The headquarters is in USA.
  9. Intellia Therapeutics

    World Rank (Aug-2026)
    7,030
    Market Cap (Aug-2026)
    1.669 Billion USD
    World Rank (Jan-05-2024)
    4,779
    Market Cap (Jan-05-2024)
    2.644 Billion USD
    World Rank (Jul-30-2023)
    3,722
    Market Cap (Jul-30-2023)
    3.734 Billion USD
    World Rank (Dec-25-2022)
    4,066
    Market Cap (Dec-25-2022)
    3.016 Billion USD
    World Rank (Jan-07-2022)
    2,284
    Market Cap (Jan-07-2022)
    7.87 Billion USD
    Annual Revenue in USD
    68 Million USD
    Annual Operating Income in USD
    -441 Million USD
    Annual Net Income in USD
    -413 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Intellia Therapeutics is a Biotechnology company. The company annual revenue is 43.2 million USD, total assets is 334.2 million USD and 211 employees as on 2019. The headquarters is in USA.

  10. Fortrea Holdings Inc.

    World Rank (Aug-2026)
    7,060
    Market Cap (Aug-2026)
    1.656 Billion USD
    World Rank (Jan-05-2024)
    4,424
    Market Cap (Jan-05-2024)
    2.958 Billion USD
    World Rank (Jul-30-2023)
    4,640
    Market Cap (Jul-30-2023)
    2.749 Billion USD
    Annual Revenue in USD
    2,723 Million USD
    Annual Operating Income in USD
    -873 Million USD
    Annual Net Income in USD
    -986 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country

Share

Ads